Browsing eNauka
Browsing by Author Bećarević, Mirjana
Showing results 1 to 20 of 44
next >
Issue Date | Title | Author(s) | Type | Мp-cat. |
---|---|---|---|---|
2012 | Adiponectin, non-esterified fatty acids and antiphospholipid antibodies in type II diabetes mellitus | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2019 | Adiponectin: a therapeutic target in the antiphospholipid syndrome?![]() | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2018 | Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome![]() | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2005 | Anti-oxLDL antibodies - marker for arterial thromboses in antiphospholipid syndrome![]() | Bećarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | Mp. category will be shown later |
2006 | Anti-oxLDL antibodies, homocysteine and apolipoproteins in primary antiphospholipid syndrome![]() | Bećarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | Mp. category will be shown later |
2017 | Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome—Biomarkers of the Disease and Biopharmaceuticals | Bećarević, Mirjana ![]() ![]() | Article | 22M22 |
2017 | Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data![]() | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2022 | Antiphospholipid antibodies in healthy serbian middle-aged subjects: preliminary data![]() | Bećarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2021 | Antiphospholipid antibodies in patients with Graves’ orbitopathy: preliminary data![]() | Bećarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2013 | Apoptosis, annexin a5 and anti-Annexin a5 antibodies in the antiphospholipid syndrome | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2011 | Association of tnf-alpha and anticardiolipin antibodies in type ii diabetes mellitus![]() | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2015 | Biofarmaceutici - monoklonska antitela u dijagnostici i terapiji autoimunih inflamatornih oboljenja | Bećarević, Mirjana ![]() ![]() | Monograph | Mp. category will be shown later |
2012 | Biofarmaceutske karakteristike preparata u tretmanu antifosfolipidnog sindroma | Bećarević, Mirjana ![]() ![]() | Monograph | Mp. category will be shown later |
2022 | Biofarmacija | Bećarević, Mirjana ![]() ![]() | Text book | Mp. category will be shown later |
2022 | Biofarmacija![]() | Bećarević, Mirjana ![]() ![]() | Text book | Mp. category will be shown later |
2023 | Biofarmacija 2![]() | Bećarević, Mirjana ![]() ![]() | Text book | Mp. category will be shown later |
2012 | Deterioration of Thromboses in Primary Antiphospholipid Syndrome: TNF-alpha and Anti-Annexin A5 Antibodies | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2017 | Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha | Bećarević, Mirjana ![]() ![]() | Article | 22M22 |
2016 | Double positivity of the IgG isotype of both anticardiolipin and anti-beta 2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data | Becarević, Mirjana ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2018 | Exposure to potential drug-antimicrobial agent interactions in primary health care![]() | Nikolić, Božana ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |